Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Killer immunoglobulin-like receptor 2DL3 (KIR2DL3)
- Target
- KIR2DL3
- Molecular classification
- Receptor, Transmembrane glycoprotein
01
Overview
Killer immunoglobulin-like receptor 2DL3 (KIR2DL3) is an inhibitory receptor expressed on NK cells and some T cells. It binds to HLA-C allotypes (Cw1, Cw3, Cw7) and transmits inhibitory signals to prevent NK cell activation and lysis of target cells. It plays a role in immune regulation and self-tolerance. Dysregulation can contribute to pathological conditions such as cancer or impaired immune responses. Clinical studies have shown associations between certain KIR/HLA combinations—including those involving KIR2DL3—and outcomes in infectious diseases like hepatitis C virus infection clearance.
02
Mechanism of action
Inhibits NK cell activation/lysis via ITIM signaling upon binding to HLA-C ligands.
03
Biological functions
Immune responseInhibitory signalingRegulation of NK cell activityMaintenance of self-tolerance
04
Disease associations
InfectionCancerImmune dysregulation
Beyond the preview
Go deeper on Killer immunoglobulin-like receptor 2DL3 (KIR2DL3).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Follow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Compare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Investigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Explore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Connect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Killer immunoglobulin-like receptor 2DL3 (KIR2DL3).